NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We do
    • Strategic Partnership Board
    • Steering Committee
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
  • Patient & Public Involvement
        • About Patient & Public Involvement

        • Our work with patients and the public
        • Our Work with Schools
        • Patient Involvement Blog
        • External Links
        • For Patients, Carers & Members of the Public

        • About Patients Active in Research
        • Listings for Patients Active in Research
        • Register interest in involvement
        • Patient and Public Involvement Workshops 2019/20
        • Oxford Blood Group (within Haematology & Stem Cells research theme)
        • For Researchers

        • PPI Strategy
        • A Researcher's Guide to PPI
        • PPI Resources for Researchers
        • PPI Briefing Notes for Researchers
        • PPI Case Studies
        • Post a Listing for Patient & Public Involvement
  • Professional & Training
        • Professional Partnerships
        • Case Studies – Early Careers Researchers
          • Early Career Profile: Teresa Lambe
          • Early Career Profile: Dr Jasmina Cehajic Kapetanovic
          • Early Career Profile: Sara Khalid
          • Early Career Profile: Chantal Hargreaves
          • Early Career Profile: Kate Tudor
        • Useful Links
        • Research Education and Training
        • Support from the NIHR Oxford BRC
          • Oxford BRC Small Grants in Health Sciences
          • Doctoral awards for nurses, midwives and allied health professionals
          • Senior Fellows Competition
          • Training bursaries for affiliated research nurses, midwives, scientists and allied health professionals
          • Preparatory research career fellowships for nurses, midwives and allied health professionals
        • Funding from other Providers
        • Training Opportunities
        • Education Resources
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Antimicrobial Resistance and Modernising Microbiology > Oxford team use DNA sequencing and patient data to halt infection outbreak

Oxford team use DNA sequencing and patient data to halt infection outbreak

3 October 2018 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data

Tweet about this on Twitter
Twitter
Share on Facebook
Facebook
Share on LinkedIn
Linkedin
Share

Clinical and research teams at Oxford University Hospitals (OUH) NHS Foundation Trust, using infection prevention and control best practice, whole genome sequencing and electronic patient data, have halted an outbreak of a potentially deadly fungal pathogen after detecting that multi-use patient equipment was responsible.

The breakthrough at the John Radcliffe Hospital is significant as this is the first time an outbreak of Candida auris (C. auris) has been completely ended with a clear understanding of the cause.

The study, published on 3 October by the New England Journal of Medicine, was conducted by the Infection, Prevention and Control and Neurosciences Intensive Care Unit (ICU) teams from OUH, the University of Oxford’s Nuffield Department of Medicine, the Big Data Institute and the NIHR Health Protection Research Unit and Public Health England, and supported by the NIHR Oxford Biomedical Research Centre.

The lead investigator, Dr David Eyre, Research Fellow in Infectious Diseases at the Big Data Institute, said: “It is very pleasing that our research has led to the C. auris outbreak being stopped. There are a number of hospitals in the UK and around the world that have been unable to halt their outbreaks. Working out how it is transmitted should help to contain its spread worldwide.”

“Such is the nature of this pathogen that we must remain vigilant, and we’re delighted that, since we changed our approach as a result of our findings, we have had no further cases.”

C. auris is an emerging, multi-drug resistant fungal pathogen recently associated with outbreaks worldwide, often in intensive care units. In some patients, C. auris can enter the bloodstream and spread throughout the body, causing serious infection.

The researchers investigated a large C. auris outbreak at the John Radcliffe Hospital’s Neurosciences ICU between 2015 and 2017, during which 70 patients were identified as being colonised or infected with C. auris.

Using whole genome sequencing of patient and environmental isolates, combined with electronic health record data, they studied possible transmission routes, risk factors for colonisation and the molecular epidemiology of the outbreak.

Patients in Neurosciences ICU were regularly screened for C. auris, as were those on the adjacent Neurosciences ward. Samples were also taken from the environment, focusing on sampling high-touch areas and multi-use devices.

“We found that C. auris was rarely detected in the general environment; there was no trace of the organism on surfaces within the unit and only 1 out of 16 air samples was positive,” Dr Eyre explained.

“However, we did find C. auris on multi-use patient equipment, particularly temperature probes. There were close genetic matches between C. auris isolated from patients and from these thermometers. We found that having their temperature monitored with one of these probes was an important risk factor for acquiring C. auris. And unlike with pathogens like C. difficile, bed proximity did not appear to be a factor in transmission.

“So our research clearly showed that environmental survival appears to be key to Candida auris’s persistence and transmission in healthcare settings. This led to us implementing successful infection control measures to contain the outbreak – including removing multi-use skin surface thermometers from use,” he said.

Professor Derrick Crook, Director of National Infection Service at Public Health England and Antimicrobial Resistance Theme Lead at the NIHR Oxford Biomedical Research Centre, said: “This study will feed directly into healthcare guidelines regarding the use of multi-use equipment, and in particular the decontamination of this equipment in the event of future outbreaks.

“Although a relatively small number of patients in the Oxford study had clinically significant C. auris infections, such infections can have serious consequences for the kind of vulnerable patients admitted to intensive care units, particularly as C. auris is highly resistant to many anti-fungal agents. The action that was taken as a result of this research undoubtedly prevented more patients becoming colonised and infected.”

← UK-led study marks shift towards genetic era in tackling TB
Award-winning citizen science project tackling TB gets millionth classification →

News

  • All-singing all-dancing research at the Oxford Science and Ideas Festival 31 October 2019
  • Promising therapy for common form of eczema identified in early-stage trial 24 October 2019
  • Severe reactions to grief can be predicted and treated in the first months following a bereavement 8 October 2019
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced bimonthly and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Cookies

This site uses cookies See our data control and privacy page